Posts

Multiplex Assays Market Set to Reach USD 10.65 Billion by 2031 Amid Rising Demand for Advanced Diagnostics

  The global healthcare landscape is undergoing a significant transformation driven by the increasing need for rapid, accurate, and high-throughput diagnostic solutions. Among the technologies gaining considerable momentum are multiplex assays, which enable the simultaneous detection and analysis of multiple biomarkers from a single sample. According to recent market research, the global multiplex assays market is projected to grow from USD 7.15 billion in 2026 to USD 10.65 billion by 2031, registering a CAGR of 8.3% during the forecast period . The market’s expansion is being fueled by rising incidences of infectious diseases, cancer, and autoimmune disorders, coupled with growing investments in precision medicine and advanced diagnostic technologies. As healthcare systems increasingly prioritize early disease detection and personalized treatment approaches, multiplex assays are emerging as indispensable tools across research and clinical settings. Download PDF Brochure Growing ...

Microcarriers Market Poised to Reach USD 3.05 Billion by 2029 Driven by Rising Demand for Cell and Gene Therapies

  The global healthcare industry is undergoing a significant transformation, with advanced therapies, regenerative medicine, and biologics reshaping the future of disease treatment. At the center of this evolution lies the microcarriers market, which is witnessing strong growth due to increasing demand for large-scale cell culture technologies used in vaccine production, cell and gene therapy, and stem cell research. According to recent market analysis, the global microcarriers market is projected to grow from USD 2.08 billion in 2024 to USD 3.05 billion by 2029 , registering a compound annual growth rate (CAGR) of 8.0% during the forecast period. Growing prevalence of cancer, increasing focus on cell-based vaccines, and expanding applications of advanced therapies are among the major factors fueling market expansion. Download PDF Brochure Understanding Microcarriers and Their Importance Microcarriers are small beads that provide a surface for the attachment and growth of adheren...

Radioligand Therapy (RLT) Market Poised to Reach USD 10.91 Billion by 2035, Driven by Advances in Precision Oncology

  Radioligand therapy (RLT) is emerging as one of the most promising approaches in precision oncology, offering targeted treatment options for patients with difficult-to-treat cancers. According to recent market research, the global Radioligand Therapy (RLT) Market is projected to grow from USD 3.15 billion in 2025 to USD 10.91 billion by 2035 , registering a robust CAGR of 13.2% during the forecast period. The rapid expansion of the market reflects the growing importance of targeted radiopharmaceuticals in modern cancer care. Increasing cancer incidence, continuous innovation in radiolabeled therapeutics, expanding regulatory approvals, and strategic collaborations among pharmaceutical and biotechnology companies are collectively accelerating market growth. Download PDF Brochure Rising Demand for Precision Oncology Fuels Market Expansion Radioligand therapy combines the specificity of molecular targeting with the cancer-killing effects of radiation. By delivering radioactive ...

AI in Pathology Market Poised to Reach USD 347.4 Million by 2030 Amid Rapid Advances in Digital Diagnostics

Artificial intelligence (AI) is transforming pathology by enabling faster, more accurate, and highly scalable diagnostic processes. As healthcare systems worldwide embrace digital technologies, AI-powered pathology solutions are becoming indispensable for disease detection, image interpretation, clinical decision support, and drug development. According to a recent MarketsandMarkets report, the global AI in Pathology Market is projected to grow from USD 107.4 million in 2025 to USD 347.4 million by 2030 , registering an impressive CAGR of 26.5% during the forecast period. The market's expansion is being driven by rapid advancements in neural networks, growing adoption of digital pathology platforms, and increasing demand for precision medicine. Growing Need for AI in Modern Pathology Pathology plays a critical role in diagnosing diseases and guiding treatment decisions. However, rising patient volumes, shortages of skilled pathologists, and increasing diagnostic complexity ...

Laboratory Informatics Market to Reach USD 10.12 Billion by 2030 Driven by Digital Transformation in Laboratories

  The global Laboratory Informatics Market is witnessing strong momentum as laboratories across pharmaceuticals, biotechnology, healthcare, food testing, environmental sciences, and research institutions accelerate digital transformation initiatives. The market is projected to grow from USD 6.31 billion in 2025 to USD 10.12 billion by 2030, registering a CAGR of 9.9% during the forecast period. Download PDF Brochure Understanding the Laboratory Informatics Market Laboratory informatics refers to the integration of software, analytics, and data management systems that streamline laboratory workflows, improve operational efficiency, ensure regulatory compliance, and enhance data accuracy. These solutions are widely adopted in laboratories to manage complex datasets, automate processes, and support scientific decision-making. The increasing demand for data-driven laboratory operations, rising R&D investments, and the growing need for regulatory compliance are major factors fueli...